Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development

Human existence can be viewed as an “animal in a microbial world.” A healthy interaction of the human host with the microbes in and around us heavily relies on a well-functioning immune system. As development of both the microbiota and the host immune system undergo rapid changes in early life, it i...

Full description

Bibliographic Details
Main Authors: Nelly Amenyogbe, Tobias R. Kollmann, Rym Ben-Othman
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-05-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fped.2017.00111/full
id doaj-6e51fca7cb0e49de9d5f03caec0cf5c4
record_format Article
spelling doaj-6e51fca7cb0e49de9d5f03caec0cf5c42020-11-24T22:30:42ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602017-05-01510.3389/fped.2017.00111253413Early-Life Host–Microbiome Interphase: The Key Frontier for Immune DevelopmentNelly Amenyogbe0Tobias R. Kollmann1Rym Ben-Othman2Department of Experimental Medicine, University of British Columbia, Vancouver, BC, CanadaDepartment of Pediatrics, University of British Columbia, Vancouver, BC, CanadaDepartment of Pediatrics, University of British Columbia, Vancouver, BC, CanadaHuman existence can be viewed as an “animal in a microbial world.” A healthy interaction of the human host with the microbes in and around us heavily relies on a well-functioning immune system. As development of both the microbiota and the host immune system undergo rapid changes in early life, it is not surprising that even minor alterations during this co-development can have profound consequences. Scrutiny of existing data regarding pre-, peri-, as well as early postnatal modulators of newborn microbiota indeed suggest strong associations with several immune-mediated diseases with onset far beyond the newborn period. We here summarize these data and extract overarching themes. This same effort in turn sets the stage to guide effective countermeasures, such as probiotic administration. The objective of our review is to highlight the interaction of host immune ontogeny with the developing microbiome in early life as a critical window of susceptibility for lifelong disease, as well as to identify the enormous potential to protect and promote lifelong health by specifically targeting this window of opportunity.http://journal.frontiersin.org/article/10.3389/fped.2017.00111/fullmicrobiomeimmunity and infectionsontogenyimmune diseasesprobiotics
collection DOAJ
language English
format Article
sources DOAJ
author Nelly Amenyogbe
Tobias R. Kollmann
Rym Ben-Othman
spellingShingle Nelly Amenyogbe
Tobias R. Kollmann
Rym Ben-Othman
Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development
Frontiers in Pediatrics
microbiome
immunity and infections
ontogeny
immune diseases
probiotics
author_facet Nelly Amenyogbe
Tobias R. Kollmann
Rym Ben-Othman
author_sort Nelly Amenyogbe
title Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development
title_short Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development
title_full Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development
title_fullStr Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development
title_full_unstemmed Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development
title_sort early-life host–microbiome interphase: the key frontier for immune development
publisher Frontiers Media S.A.
series Frontiers in Pediatrics
issn 2296-2360
publishDate 2017-05-01
description Human existence can be viewed as an “animal in a microbial world.” A healthy interaction of the human host with the microbes in and around us heavily relies on a well-functioning immune system. As development of both the microbiota and the host immune system undergo rapid changes in early life, it is not surprising that even minor alterations during this co-development can have profound consequences. Scrutiny of existing data regarding pre-, peri-, as well as early postnatal modulators of newborn microbiota indeed suggest strong associations with several immune-mediated diseases with onset far beyond the newborn period. We here summarize these data and extract overarching themes. This same effort in turn sets the stage to guide effective countermeasures, such as probiotic administration. The objective of our review is to highlight the interaction of host immune ontogeny with the developing microbiome in early life as a critical window of susceptibility for lifelong disease, as well as to identify the enormous potential to protect and promote lifelong health by specifically targeting this window of opportunity.
topic microbiome
immunity and infections
ontogeny
immune diseases
probiotics
url http://journal.frontiersin.org/article/10.3389/fped.2017.00111/full
work_keys_str_mv AT nellyamenyogbe earlylifehostmicrobiomeinterphasethekeyfrontierforimmunedevelopment
AT tobiasrkollmann earlylifehostmicrobiomeinterphasethekeyfrontierforimmunedevelopment
AT rymbenothman earlylifehostmicrobiomeinterphasethekeyfrontierforimmunedevelopment
_version_ 1725739823863431168